smoking and glp 1 Smokers less likely to receive GLP-1 than nonsmokers GLP-1s for Smokers: Quitting without

Stem Cell Res

Fat isnt bad

a , mRNA abundance of complex I subunits in adipocytes from the gWAT depot of Control ( Bmal1 fx/fx ) and Bmal1 -KO ( Adiponectin-Cre

When the Breakthrough Obesity G-Agonist Drugs Exceed Expectations The expanding GLP-1 family of drugs and their expanded potential use cases Back last December I wrote about the The New Obesity Breakthrough Drugs, and specifically the striking results in randomized trials for semaglutide (Wegovy) and tirzepatide (Mounjaro) for weight loss, their putative mechanism(s), while also emphasizing their very high cost, lack of plan for successful weaning, and exacerbation of health inequities